Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06877104 · ClinicalTrials.gov registry record · NA
Healing at Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression
A NA study of Depression, Postpartum and Postpartum Care, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 156
- Enrollment target
- 1
- Study location
NCT06877104: Recruiting NA study of Depression, Postpartum and Postpartum Care, sponsored by University of Pennsylvania.
NCT06877104 is a NA study of Depression, Postpartum and Postpartum Care that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 156 participants, roughly in line with the 153-participant average among 15 other Depression, Postpartum trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06877104, a NA study of Depression, Postpartum and Postpartum Care, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine if access to a text-message based holistic chatbot support program "Healing at Home 2.0" decreases depressive symptoms as measured by the Edinburgh Postnatal Depression Scale (EPDS) compared to usual postpartum care for patients of color.
Primary Outcome
Scores from the validated EPDS screening tool will be calculated using standard scoring criteria for each of the 10 items. A score of 9 or greater or indication of suicide ideation will be used to indicate a positive depression screen.
Conditions Studied
Interventions
- OTHER Healing @ Home Program (H@H 2.0)
Study Locations (1)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2025-03-13 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06877104 shows while recruiting
NCT06877104 is an interventional study that assigns participants to a tested intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 153-participant average among 15 other Depression, Postpartum trials with a reported enrollment target.
The record links to 2 conditions, with Depression, Postpartum appearing as the primary indexed condition, and to 1 intervention - of which Healing @ Home Program (H@H 2.0) is the first listed.
NCT06877104 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06877104 about?
NCT06877104 is a clinical study titled "Healing at Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression". The purpose of the study is to determine if access to a text-message based holistic chatbot support program "Healing at Home 2.0" decreases depressive symptoms as measured by the Edinburgh Postnatal Depression Scale (EPDS) compared to usual postpartum care for patients of color.
What is the current status of trial NCT06877104?
This trial is currently recruiting. It is a NA study. The enrollment target is 156 participants. The study started on 2025-03-13. Estimated completion is 2026-06-30.
What conditions does trial NCT06877104 study?
This clinical trial studies the following conditions: Depression, Postpartum, Postpartum Care.
What interventions are being tested in trial NCT06877104?
The interventions under investigation include: Healing @ Home Program (H@H 2.0) (OTHER).
Who is sponsoring clinical trial NCT06877104?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06877104 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression, Postpartum
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06877104's enrollment target sits among peer trials
156 7th of 15 higher than 9 of 15 other Depression, Postpartum trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression, Postpartum trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMAGINE: Pilot Trial of a Digital Group Intervention to Prevent Perinatal Depression
RECRUITING · NA
-
HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis
RECRUITING · NA
-
Enhancing Mental and Physical Health of Women Veterans
ACTIVE NOT RECRUITING · NA
-
CSE v. Epidural for Postpartum Depression
COMPLETED · NA
-
Tracking Depression Symptoms With a Health Chatbot
COMPLETED · NA
-
Doula Support for Young Mothers: A Randomized Trial
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI